Intravenous Infusions Plc (GHSE:IIL)

Ghana · Delayed Price · Currency is GHS

0.5400

0.00 (0.00%)

At close: Sep 16, 2026

Market Cap	148.18M +980.0%
Revenue (ttm)	6.51M -66.4%
Net Income	-4.43M
EPS	-0.01
Shares Out	274.41M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	51,124
Open	n/a
Previous Close	0.5400
Day's Range	n/a
52-Week Range	0.0500 - 0.8600
Beta	-0.60
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 18, 2026

About Intravenous Infusions

Intravenous Infusions Plc, a pharmaceutical company, engages in the manufacturing and marketing of intravenous infusions and small volume injectables for therapeutic purposes in Ghana and the West African sub-region. It provides pethidine, such as chloroquine phosphate and quinine dihydrochloride injections. The company was incorporated in 1969 and is based in Koforidua, Ghana. [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries

Founded 1969

Country Ghana

Stock Exchange Ghana Stock Exchange

Ticker Symbol IIL

Full Company Profile

Financial Performance

In 2025, Intravenous Infusions's revenue was 9.30 million, a decrease of -62.69% compared to the previous year's 24.94 million. Losses were -4.63 million, 620.5% more than in 2024.

Financial Statements